Dallas, Texas (PRWEB) February 21, 2013
"Egypt’s Healthcare Expansion to Continue despite Deep Civil Unrest. Despite a number of major socio-political issues, including widespread public discontent and political instability, Egypt’s healthcare sector will demonstrate relatively impressive growth in the future, predicts research and consulting firm.
The new report Healthcare, Regulatory and Reimbursement Landscape - Egypt forecasts Egypt’s pharmaceutical market to climb from a value of US$3 billion in 2012 to US$5.3 billion in 2020, while the county’s medical devices market is expected to grow from US$789m to US$1.1 billion during the same period.
Pricing policies introduced in May 2011, which linked the price of pharmaceuticals with international prices, are expected to act as a key growth driver for Egypt’s healthcare sector in the coming years.
Additionally, last October’s proposal of a new universal healthcare law that will provide health insurance coverage to the entire Egyptian population should prove a significant boost to healthcare revenue once introduced across the country.
However, the social turmoil currently permeating Egypt has given rise to a number of significant obstacles to growth. The North African nation has a population of approximately 80 million, the majority of whom are of working-age, but unemployment levels have crept up in recent years and stood at 12.5% by the end of 2012.
Political instability has also been a major problem since the revolution in January 2011. Egypt’s economy is currently facing high inflation, a weakening of Foreign Direct Investment (FDI) and last year the country’s fiscal deficit increased to 10% – a factor that may substantially affect how much the Egyptian government allocates to healthcare spending in the future.
This report provides an overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=222442 .
Healthcare, Regulatory and Reimbursement Landscape – Colombia
In 2011, the population of Colombia was approximately 46 million, growing at a Compound Annual Growth Rate (CAGR) of 1.19%, over the 2006–2011 periods. The mortality rate declined at a CAGR of 0.07%, during 2005–2010, at approximately 5.48 deaths per 1,000 populations in 2010. The decline was due to advances in healthcare infrastructure and medical and diagnostic services. The value of the pharmaceutical market was estimated at $3.3 billion in 2010, and is expected to reach $9.2 billion by 2020, increasing at a projected CAGR of 10.8%.
The positive trends in the healthcare market of Colombia can be attributed primarily to -
- Increasing awareness of health and well-being in society
- Increasing affordability and compliance
- A strategic move by the Colombian government towards compulsory health insurance
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=222443.
Healthcare, Regulatory and Reimbursement Landscape – Switzerland
In 2011, the population of Switzerland was approximately 8 million. The population of Switzerland is increasing due to a positive balance between the counrty’s mortality and birth rates, an increasing fertility rate, and a high rate of immigration. Policymakers in Switzerland are now faced with the problems of a Eurozone crisis, a declining population of the working-age group, and an increasing elderly population. The country’s pharmaceutical market was valued at $6.6 billion in 2011 and is expected to reach approximately $10.9 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.6%. The medical device market size was approximately $2.4 billion in 2011 and is expected to reach approximately $3.6 billion by 2020, with a projected CAGR of 5%. The positive trends in the Switzerland healthcare market can be attributed primarily to -
- An increasing elderly population
- Universal healthcare insurance
- A high degree of innovation in healthcare product and services
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=222444 .
The report provides information on the healthcare, regulatory, and reimbursement landscape of Egypt, Colombia and Switzerland, including -
- An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets.
- An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices.
- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures.
- An overview of the opportunities and challenges for growth in the healthcare market.
Key player also listed for the respective countries.
ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.